Analyst	Recommendation	Action	Price target	Projected	Date
Swayampakula Ramakanth H.C. Wainwright	Buy	Reiterated	$4.00	+672.6%	09/21/2026
Josh Jennings TD Cowen	Buy	Maintained	$1.25	+141.5%	08/19/2026
Allison Bratzel Piper Sandler	Hold	Maintained	$1.00	+93.2%	08/17/2026
Ryan Zimmerman BTIG	Buy	Maintained	$2.00	+286.3%	07/28/2026
Bruce Jackson Benchmark Co.	Buy	Maintained	$2.00	+286.3%	06/01/2026
Matt Miksic Barclays	Buy	Reiterated	$1.50	+189.7%	05/13/2026

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	753.00K	467.00K	495.00K	406.00K
Cost of goods sold	17.53M	23.69M	20.90M	19.38M
Cost of revenue	17.53M	23.69M	20.90M	19.38M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	7.61M	7.62M	7.83M	8.03M
Operating expense	7.61M	7.62M	7.83M	8.03M
Total operating expenses	25.14M	31.30M	28.73M	27.40M
Operating income	-24.39M	-30.84M	-28.24M	-27.00M
Other non operating income	4.01M	20.57M	8.52M	-5.16M
EBT including unusual items	-17.51M	-24.80M	-17.62M	-36.80M
EBT excluding unusual items	-22.40M	-12.85M	-21.65M	-34.08M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-17.51M	-24.80M	-17.62M	-36.80M
Net profit margin	-2,325.37%	-5,311.35%	-3,559.39%	-9,064.53%
Earnings per share	-0.11	-0.13	-0.09	-0.16
Interest and investment income	590.00K	503.00K	330.00K	388.00K
Interest expense	-2.61M	-3.09M	-2.27M	-2.32M
Net interest expenses	-2.02M	-2.59M	-1.94M	-1.93M
Depreciation and amortization charges	-	-	-	-
EBITDA	-22.52M	-29.05M	-26.44M	-25.21M
Gain or loss from assets sale	-	5.00K	-	-

Ask anything